Do You Read All Of Our Blogs?
This page you have reached is an archive of old blog posting. Just follow the links below to go to the main blog pages to read the latest blog posting.
Do you read all of the blogs published by medicineworld.org? Many of our bloggers are busy keeping you updated on the various health related topics. We publish the following blogs at this time.
I manage the cancer blog with lots of help and support form other bloggers. Through this cancer blog my friends and I try to bring stories of hope for patients with cancer. The cancer blog often republishes important blog posts from other cancer related blogs at Medicineworld.org. If you are searching for a blog that covers wide variety of cancer topics, this may be the one for you.
Breast cancer blog:
Breast cancer blog is run by Emily and other bloggers and they bring you the latest stories, news and events that are related to breast cancer. Increasing awareness about breast cancer among women and in the general population is the main goal of this breast cancer blog.
Lung cancer blog:
Lung cancer blog is managed by Scott with the help of other bloggers. Through this blog Scott and his friends constantly remind the readers about the dangers of smoking. It's a never-ending struggle against this miserable disease with which a social stigma of smoking is associated.
Colon cancer blog:
Colon cancer blog is run by Sue and other bloggers. Sue brings a personal touch to the colon cancer blog since her mother died of colon cancer few years ago. She writes about stories, research news and advances in treatment related to colon cancer.
Prostate cancer blog:
Prostate cancer is the most common cancer among American men. American Cancer Society estimates that over 230,000 new cases of prostate cancer occur in the United state every year. This important blog about prostate cancer is run by Mark and other bloggers. This blog brings news, stories, and other personal observations related to prostate cancer.
Medicineworld.org publishes a diabetes watch blog
and this blog is run by JoAnn other bloggers. This diabetes watch blog brings you the latest in the field of diabetes. This includes personal stories, advances in diagnosis and treatment, and other observations about diabetes. Improving awareness about diabetes is an important mission of this group.
Heart watch blog:
About 13 million Americans suffer from coronary artery disease. Coronary artery disease is the leading cause of death in American men and women amounting a staggering 20 percent of all causes of death. The tremendous responsibility of running a heart blog is entrusted to Daniel. He is creating blog posts with the help and support of other bloggers.
Aug 25, 2005
Stigma associated with lung cancer
It is a pity that lung cancer has a stigma associated with the diagnosis. When someone is diagnosed with colon cancer, the society view in a difference perspective compared to someone who has been diagnosed with lung cancer. Somehow the society feels that the person who is having lung cancer caused this terrible disease to himself or herself.
I agree with the fact that smoking is the most important risk factor for lung cancer. It is also true that about ninety percent of those who are diagnosed with lung cancer are smokers. Despite all these facts, it is disturbing when the society watches someone who has been diagnosed with lung cancer, with skepticism. Unlike many other types of cancer, lung cancer is associated with very low survival rates and prejudiced outlook is the last thing a lung cancer patient deserves. It is the society's responsibility to give support to those of us who have been diagnosed with this deadly ailment.
Also it should be remembered that among those who are diagnosed with lung cancer, there are number of people who have really realized the mistake many years ago and stopped smoking. Even thought the risk of developing lung cancer markedly decreases when someone quits smoking, they still remain at very high risk of developing lung cancer for many years to come.
Of those diagnosed with lung cancer, those who have never smoked suffers additional emotional trauma, because they often cannot accept the fact that they have avoided smoking all their life, but was destined to have this terrible disease.
Let's support them, let's not forget that it can happen to us tomorrow, even if we are not smokers.
Aug 23, 2005
New technique to avoid unnecessary lung cancer surgery
Over 170,000 Americans are diagnosed with lung cancer each year. Most of them have the subtype known as non-small cell lung cancer. If someone close to you is diagnosed with non-small cell lung cancer, probably the most important question to ask is regarding the stage of his cancer. This is important because the outcome of lung cancer and possibility of surgery and a cure may greatly depend upon the stage of the disease.
Physicians often determine the stage of lung cancer using various techniques including CT scans, positron emission tomographic scans (PET scans), mediastinoscopy (examination of the chest using a special scope) or transesophageal ultrasound-guided fine needle aspiration otherwise know as EUS-FNA (passing an ultrasound probe through the esophagus and doing a biopsy using a needle).
These staging techniques do not always accurately predict the operability of lung cancer. It is reported that, up to 40 percent of all lung cancer surgeries are performed unnecessarily due to inaccurate staging from the limitations of staging techniques.
A new study has found that, if the physicians use combination of mediastinoscopy and EUS-FNA the accuracy of operability of non-small cell lung cancer could be increased markedly compared to using any one of these techniques alone. The researchers found that the combination of EUS-FNA would result in avoidance of unnecessary surgery in 16 percent of patients.
These findings come from a study conducted by Jouke T. Annema, M.D., Ph.D. and colleagues from Leiden University Medical Center in Netherlands and the study appears in the latest issue of Journal of the American Medical Association (JAMA).
Aug 22, 2005
New clinical trial for patients with bronchioloalveolar carcinoma (BAC) of lung
Bronchioloalveolar carcinoma (BAC) of the lung is a subtype of non-small cell lung cancer. About 20 percent of all non-small cell patients belong to this subtype. It is estimated that currently about 30,000 patients are living with BAC in the United States. Some data suggest that the incidence of BAC may be increasing, especially in younger, non-smoking women. Patients who have this subtype of non-small cell lung cancer typically do not respond very well to the conventional chemotherapy drugs.
Now enrollment is under way for a new clinical trial to study the effectiveness of an investigational agent in patients with bronchioloalveolar carcinoma (BAC). The trial is called PEAK trial, which is a multicenter, open-label, phase II trial that will be led in Seattle by Dr. Howard West, a leading oncology researcher affiliated with the Swedish Cancer Institute. The PEAK trial will enroll up to 150 male and female patients at 40 centers in the United States and 10 sites in Europe and Canada.
"While some patients with BAC are able to respond to therapies currently on the market, there is a subset of patients who try and fail on several rounds of chemotherapy, which can be a devastating process," says Dr. West. "This trial provides us with an additional opportunity to treat these patients while investigating the overall response rate for patients treated with this therapy."
If you are interested in participating in the PEAK trial you may call Jane Arthur, R.N. at (206) 386-6921. For general information on the trial, patients and physicians can call 1-866-835-2233.
Aug 21, 2005
More federal funding needed for lung cancer
Lung cancer is a very serious problem facing both men and women taking an estimated 163,510 American lives a year. This death rate is more than breast and prostate cancers combined. You may be surprised to know that only one half of federal research dollars go in to lung cancer research compared to breast cancer. If you take in to account the rates of deaths from both diseases the disparity in federal funding for lung cancer stands at a surprising 1 to 8 low ratio compared to federal funding for breast cancer.
You may wonder why the lung cancer, despite being the major cancer problem in both men and women, gets little attention and federal dollar support and why so little money on finding a cure for lung cancer. The reasons may be frightening and chilling. As per Dr. Joan Schiller, an oncologist at the University of Wisconsin, one reason is that there are very few survivors of lung cancer who can lobby effectively against Washington to increase federal funding as opposed to breast cancer. Another reason is the unfortunate stigmata associated with lung cancer that suffers of lung cancer caused this disease to happen to themselves, by cigarette smoking. Yet another reason may be the fatalistic view that lung cancer is just "too difficult to treat."
Whatever may be reason, the fact is that simply that federal funding for lung cancer research is obviously and significantly too low, given the facts associated with lung cancer. And those who control the federal purse strings should do something about it. It is time for the lung cancer patients and survivors to speak in one voice to increase federal funding of lung cancer.
Aug 19, 2005
How much radon gas are you breathing in?
Smoking is by far the most important risk factor for development of lung cancer. Exposure to tobacco smoke through passive smoking (inhaling tobacco smoke while staying near a smoker) is also associated with increased risk of lung cancer development.
Exposure to radon gas in your home environment is another risk factor for the development of lung cancer. The World Health Organization (WHO) estimates that radon causes up to 15% of lung cancers worldwide. Exposure to radon is easily controllable, but has not received any significant public attention so far.
More than 20,000 Americans develop lung cancer each year from radon exposure alone. Dr. Carmona, the Surgeon General of the United States urges Americans to test their homes to find out how much radon they might be breathing. He stressed the need to remedy the problem as soon as possible if the radon level is 4 pCi/L or more.
Two recently published studies show definitive evidence of an association between residential radon exposure and lung cancer. These two new studies, a North American study and a European study, both combined data from several previous residential studies. These two new studies go a step beyond earlier findings. They confirm the radon health risks predicted by occupational studies of underground miner's who breathed radon for a period of years.
It is time to check the amount of radon at your home.
Aug 18, 2005
Wait a while for your spiral CT scan
As I have mentioned in my post couple of days ago, the recent lung cancer diagnosis and sad demise of ABC's news anchor Peter Jennings and recent lung cancer diagnosis of Dana Reeve, widow of actor Christopher Reeve has heightened the awareness of lung cancer. This has resulted in an unprecedented flooding of thousands of smokers and non-smokers to doctor's office, for screening of lung cancer. Most of them want the latest state of the art imaging technique known as the spiral CT scan that is capable of detecting lung tumors as small as a size of pea. Most of them think that detecting lung cancer at such an early stage would increase the chance of living longer.
This is not always the case as explained by the experts from National Cancer Institute, American Society of Clinical Oncology and American Cancer Society. A few studies were done in the past evaluating the value of lung cancer screening in smokers, using chest X-rays and CT scans. Most of these studies have shown no survival benefit by screening. The benefits of lung cancer screening using helical CT scan is currently under evaluation in a trial called National Lung Screening Trial (NLST). Since the beneficial results using spiral CT scan are not proven yet, the experts urge people to wait for the results of the National Lung Screening Trial (NLST).
They also point out that the use of spiral CT scan may result in false high rates of false positive result (up to 60 percent) and this may result in unnecessary anxiety and unwanted medical interventions.
Aug 17, 2005
Nimotuzumab (TheraCIM) for treatment of lung cancer
Few years ago there were very few treatment options available for lung cancer. Recent years have witnessed a dramatic increase in the selection of drugs that are effective against lung cancer. Some where during the last few years the mode of treatment for lung cancer have shifted from the traditional non-specific forms of chemotherapy to more specific targeted therapy. In the last few years we have seen FDA approvals for two targeted therapies for lung cancer namely Geftinib (Iressa) and Erlotinib (Tarceva).
More and more targeted therapies are in pipeline for lung cancer. It looks like the monstrous lung cancer is slowly getting defeated. Nimotuzumab (TheraCIM) is a monoclonal antibody directed against the EGF receptor (similar in action to Iressa). Nimotuzumab has demonstrated very encouraging results in both children and adults with brain cancer. Now YM BioSciences, manufacturer of Nimotuzumab, is proceeding to clinical trials in lung cancer using this new drug. The proposed randomized Non-Small-Cell Lung Cancer (NSCLC) trial will compare the effects of the combination of nimotuzumab with radiation against radiation alone in selected patients with stage IIB and III disease. This drug is also currently undergoing a Phase II monotherapy trial in Europe in patients with advanced metastatic pancreatic cancer." A recent study using nimotuzumab in combination with radiation therapy for nasopharyngeal cancer patients has completed in China and has demonstrated substantial benefit. Based on this finding nimotuzumab resulting in drug approved for sale in China.
Aug 16, 2005
Never-ending struggle with lung cancer
We engage a never-ending daily struggle to understand and defeat the hidden mysteries of cancer. This is a long and laborious fight, but some moments stand out as grim reminders of the severity of the problem and ruthlessness of the enemy. We recently heard about the sad demise of Peter Jennings, who was the news anchor of ABC News for a long time. He was determined to fight his lung cancer, but he could sustain only four months since his diagnosis. Now Dana Reeve, widow of actor Christopher Reeve, who have never been a smoker is diagnosed with lung cancer. Even though these are sad incidents, they bring a renewed public attention to the grim reality and magnitude of problem caused by lung cancer. It is a reality that lung cancer kills 160,000 Americans every year. Many of them are our friends; some of them are our relatives and family members. This cruel reality reminds us of the damages caused by smoking. Even though lung cancer can affect non-smokers, the great majority of lung cancer patients are smokers. Eighty to ninety percent of lung cancer occurs in smokers. We should focus our attention at prevention and stopping of smoking is plays the central role in this struggle. Early detection and discovery of better treatment options are also other aspects, which need immediate attention.